(lp0
S'Novelion Therapeutics Inc  Given Average Rating of &quot;Buy&quot; by Brokerages The Cerbat Gem - 1 hour ago Novelion Therapeutics logo Novelion Therapeutics Inc   has earned a consensus broker rating score of 2.33  from the three brokers that cover the stock, Zacks Investment Research reports.The RBC Capital Markets Lowers Novelion Therapeutics Inc.  Price Target ... - Petro Global News 24'
p1
aS'Kingstown Capital Partners is Buying Novelion Therapeutics Inc. (NASDAQ:NVLN ... Small Cap Exclusive  - Apr 6, 2017 In a just published Form 13, filed with the US Securities and Exchange Commission , Novelion Therapeutics Inc.  reported that Kingstown Capital Partners, Llc.'
p2
aS'Novelion Therapeutics Appoints Mark Corrigan, MD to Board of Directors GlobeNewswire  - Mar 31, 2017 VANCOUVER, British Columbia, March 31, 2017  -- Novelion Therapeutics Inc.  , a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases, today announced ...Novelion Therapeutics  Appoints Mark Corrigan to Board of Directors - StreetInsider.comZacks: Analysts Set $11.88 Target Price for Novelion Therapeutics Inc  - The Cerbat Gem'
p3
aS"What Are the Numbers Saying About: Novelion Therapeutics Inc.  SKV News - 15 hours ago Novelion Therapeutics Inc. 's 12 month volatility is currently 47.357500. The 6 month volatility is 320.841500, and the 3 month is noted at 29.561000."
p4
aS'The Novelion Therapeutics Inc.  Given New $10.00 Price Target at RBC ... Petro Global News 24 - 5 hours ago Several other research analysts also recently weighed in on NVLN. Zacks Investment Research upgraded shares of Novelion Therapeutics from a hold rating to a buy rating and set a $2.00 target price for the company in a research note on Tuesday,&nbsp;...'
p5
aS'Zacks: Brokerages Set $11.88 Target Price for Novelion Therapeutics Inc  The Cerbat Gem - Mar 29, 2017 Novelion Therapeutics logo Novelion Therapeutics Inc   has been given a consensus broker rating score of 0.00  from the two analysts that cover the stock, Zacks Investment Research reports.'
p6
aS"Novelion Therapeutics Inc.  Files An 8-K Changes in Registrant's ... Market Exclusive - Apr 13, 2017 Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases.613277 Shares in Novelion Therapeutics Inc  Acquired by Fmr LLC - Markets DailyThe Cutler Group LP Has $162000 Position in Novelion Therapeutics Inc  - Petro Global News 24"
p7
aS'Two Sigma Investments LP Purchases Shares of 23795 Novelion Therapeutics Inc ... BNB Daily  - Apr 8, 2017 Novelion Therapeutics logo Two Sigma Investments LP purchased a new position in Novelion Therapeutics Inc   during the fourth quarter, Holdings Channel reports.'
p8
aS'Mirati Therapeutics Inc.  Settles Into New 52-Week Low on April 17 Session Equities.com - 12 hours ago Mirati Therapeutics Inc is a biopharmaceutical company that discovers, develops, and commercializes novel therapeutics with an initial focus on cancer and infectious diseases.'
p9
aS'Renaissance Technologies LLC Takes Position in Novelion Therapeutics Inc  BBNS - Apr 15, 2017 Novelion Therapeutics logo Renaissance Technologies LLC acquired a new stake in Novelion Therapeutics Inc   during the fourth quarter, Holdings Channel reports.'
p10
a.